Stevens Scott M, Woller Scott C, Kreuziger Lisa Baumann, Bounameaux Henri, Doerschug Kevin, Geersing Geert-Jan, Huisman Menno V, Kearon Clive, King Christopher S, Knighton Andrew J, Lake Erica, Murin Susan, Vintch Janine R E, Wells Philip S, Moores Lisa K
Department of Medicine, Intermountain Healthcare, Murray, UT.
Department of Medicine, Intermountain Healthcare, Murray, UT.
Chest. 2021 Dec;160(6):e545-e608. doi: 10.1016/j.chest.2021.07.055. Epub 2021 Aug 2.
This is the 2nd update to the 9th edition of these guidelines. We provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.
We generate strong and weak recommendations based on high-, moderate-, and low-certainty evidence, using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology.
The panel generated 29 guidance statements, 13 of which are graded as strong recommendations, covering aspects of antithrombotic management of VTE from initial management through secondary prevention and risk reduction of postthrombotic syndrome. Four new guidance statements have been added that did not appear in the 9th edition (2012) or 1st update (2016). Eight statements have been substantially modified from the 1st update.
New evidence has emerged since 2016 that further informs the standard of care for patients with VTE. Substantial uncertainty remains regarding important management questions, particularly in limited disease and special patient populations.
这是这些指南第9版的第二次更新。我们针对17个PICO(人群、干预措施、对照、结局)问题提供了建议,其中4个问题此前未涉及。
我们使用GRADE(推荐分级、评估、制定和评价)方法,基于高、中、低确定性证据生成强推荐和弱推荐。
专家组制定了29条指导声明,其中13条被评为强推荐,涵盖了静脉血栓栓塞症(VTE)抗栓治疗管理从初始治疗到二级预防以及降低血栓后综合征风险等方面。新增了4条在第9版(2012年)或第一次更新版(2016年)中未出现的指导声明。与第一次更新版相比,有8条声明进行了大幅修改。
自2016年以来出现了新证据,进一步为VTE患者的护理标准提供了依据。在重要的管理问题上仍存在很大不确定性,尤其是在疾病有限的情况和特殊患者群体中。